Togashi, K.; Hatakeyama, S.; Soma, O.; Okita, K.; Fujita, N.; Tanaka, T.; Noro, D.; Horiguchi, H.; Uemura, N.; Iwane, T.;
et al. Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers. Cancers 2022, 14, 6229.
https://doi.org/10.3390/cancers14246229
AMA Style
Togashi K, Hatakeyama S, Soma O, Okita K, Fujita N, Tanaka T, Noro D, Horiguchi H, Uemura N, Iwane T,
et al. Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers. Cancers. 2022; 14(24):6229.
https://doi.org/10.3390/cancers14246229
Chicago/Turabian Style
Togashi, Kyo, Shingo Hatakeyama, Osamu Soma, Kazutaka Okita, Naoki Fujita, Toshikazu Tanaka, Daisuke Noro, Hirotaka Horiguchi, Nozomi Uemura, Takuro Iwane,
and et al. 2022. "Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers" Cancers 14, no. 24: 6229.
https://doi.org/10.3390/cancers14246229
APA Style
Togashi, K., Hatakeyama, S., Soma, O., Okita, K., Fujita, N., Tanaka, T., Noro, D., Horiguchi, H., Uemura, N., Iwane, T., Okamoto, T., Yamamoto, H., Yoneyama, T., Hashimoto, Y., & Ohyama, C.
(2022). Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers. Cancers, 14(24), 6229.
https://doi.org/10.3390/cancers14246229